CurrentEndo
Get Weekly

CurrentEndo coverage · page 13 of 55

Diabetes, Obesity and Metabolism

Briefs 481–520 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Differential Impact of Body Mass Index on Recurrence, Cardiac Remodelling, and Quality of Life After Atrial Fibrillation Ablation: Insights From the China‐ AF Registry

    Cohort studyObesity

  2. Diabetes Obes Metab

    Defining Obesity Under the Lancet Commission Criteria: Metabolic Syndrome–Anchored Body Fat Percentage Thresholds in Korean Adults

    Cross-sectional studyObesity

  3. Diabetes Obes Metab

    Impact of Real Time, Flash and Retrospective Continuous Glucose Monitoring on Feto‐Maternal Outcomes in Women With Gestational Diabetes and Pre‐Gestational Diabetes: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials

    Meta-analysisDiabetes in pregnancy

  4. Diabetes Obes Metab

    Adherence to the EAT ‐Lancet Diet, Genetic Susceptibility and Risk of Obesity and Obesity‐Related Morbidities: A Prospective Cohort Study

    Cohort studyObesity

  5. Diabetes Obes Metab

    Efficacy and Safety of Olezarsen in Hypertriglyceridemia: An Updated Meta‐Analysis of Randomised Controlled Trials

    Meta-analysisLipids & liver

  6. Diabetes Obes Metab

    Interrelationship Between Baseline HbA1c , SGLT ‐2 Inhibitor Use and Risk of Diabetic Ketoacidosis in Adults With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

    Meta-analysisComplications

  7. Diabetes Obes Metab

    Chronic Glycaemic Control Modulates the Relationship Between GIP and Glucagon Secretion Following Oral and Enteral Nutrients in Type 2 Diabetes

    Secondary analysisT2D & other

  8. Diabetes Obes Metab

    Risk Stratification of Chronic Kidney Disease in Adults Using Noninvasive Fibrosis Tests Based on the American Diabetes Association Algorithm

    Cohort studyLipids & liver

  9. Diabetes Obes Metab

    Predictors of Exercise Performance in Type 1 Diabetes: The Role of Hypoglycaemia Fear, Glycaemic Control, and Vascular Health: A Retrospective Cross‐Sectional Study

    Cross-sectional studyT1D

  10. Diabetes Obes Metab

    Distinct Motivational Profiles Based on Self‐Determination Theory Among Young and Middle‐Aged Adults With Prediabetes: Associations With Self‐Management

    Cross-sectional studyT2D & other

  11. Diabetes Obes Metab

    Efficacy and Safety of Apolipoprotein C‐ III Inhibitors in Hypertriglyceridemia: A Network Meta‐Analysis of Randomised Controlled Trials

    Meta-analysisLipids & liver

  12. Diabetes Obes Metab

    Exercise Metabolic Flexibility in Type 2 Diabetes Treated With Empagliflozin: An Exploratory Analysis of the Randomised Trial EMPA ‐ HEART

    Secondary analysisT2D & other

  13. Diabetes Obes Metab

    Impact of Sodium‐Glucose Cotransporter‐2 Inhibitors on Quality of Life and Patient‐Reported Outcomes in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis

    Meta-analysisT2D & other

  14. Diabetes Obes Metab

    Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model‐Informed Drug Development Approach

    Research articleObesity

  15. Diabetes Obes Metab

    Albuminuria and Carotid Atherosclerosis in Type 1 Diabetes Evaluated Using Three‐Dimensional Vascular Ultrasound

    Cross-sectional studyT1D

  16. Diabetes Obes Metab

    Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP ‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

    Cohort studyT2D & other

  17. Diabetes Obes Metab

    Glycaemic Outcomes of a Novel Model‐Predictive‐Control‐Based Hybrid Closed‐Loop System in Chinese Adolescents and Adults With Type 1 Diabetes: A Multicentre Pivotal Trial

    Research articleTechnology

  18. Diabetes Obes Metab

    The Risk of Disease Progression of Type 1 Diabetes in First‐Degree Relatives of People With Type 1 Diabetes: Design and Rationale of a Prospective, Longitudinal Study in China

    Trial designT1D

  19. Diabetes Obes Metab

    Swimming With the Omnipod 5 Automated Insulin Delivery System: An Observational Investigation of Swimmers With Type 1 Diabetes in the Omnipod 5 Pivotal Trial

    Cohort studyTechnology

  20. Diabetes Obes Metab

    Effect of Metformin Treatment on Gonadotropin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis of 51 Randomised Controlled Trials

    Meta-analysisReproductive endocrine

  21. Diabetes Obes Metab

    Real‐World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non‐Diabetic Adults

    Cohort studyObesity

  22. Diabetes Obes Metab

    Glycemic Variability Bridges Time in Range and Time in Tight Range: A Unified Equation for Both Type 1 and Type 2 Diabetes Based on Large‐Scale Continuous Glucose Monitoring Data

    Cross-sectional studyTechnology

  23. Diabetes Obes Metab

    Efficacy and Safety of Automated Insulin Delivery in People With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

    Meta-analysisTechnology

  24. Diabetes Obes Metab

    Body Roundness Index and All‐Cause Mortality in Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Dual‐Cohort Study

    Cohort studyLipids & liver

  25. Diabetes Obes Metab

    Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes

    Meta-analysisT2D & other

  26. Diabetes Obes Metab

    SEMASEARCH Study Design: Real‐World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials

    Trial designObesity

  27. Diabetes Obes Metab

    Polygenic Risk Score Predicts Prostate Cancer Risk Independent of Type 2 Diabetes

    Cohort studyT2D & other

  28. Diabetes Obes Metab

    Efficacy and Safety of Fixed‐Dose Combinations of Sitagliptin and Empagliflozin as Add‐On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double‐Blind, Multi‐Centre, Placebo‐Controlled, Phase III Trial

    Randomized controlled trialT2D & other

  29. Diabetes Obes Metab

    Dementia Burden and Modifiable Risk Factors in Type 2 Diabetes: Population Based, Prospective Cohort Study

    Cohort studyT2D & other

  30. Diabetes Obes Metab

    Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study

    Cohort studyObesity

  31. Diabetes Obes Metab

    Proteomic Profiling of Plasma to Uncover Novel Intervention Targets and Prognostic Biomarkers for Chronic Liver Diseases

    Diagnostic or prognostic studyLipids & liver

  32. Diabetes Obes Metab

    Glycemic Control During the Menstrual Cycle in Women With Type 1 Diabetes: Performance of an Automated Insulin Delivery System

    Cohort studyTechnology

  33. Diabetes Obes Metab

    Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials

    Meta-analysisObesity

  34. Diabetes Obes Metab

    Use of Oral Semaglutide and Associated Clinical Outcomes in Thai Patients With Type 2 Diabetes: Real‐World Evidence From the REALISED Study

    Cohort studyT2D & other

  35. Diabetes Obes Metab

    Waist‐to‐Height Ratio and the Risk of Cardiovascular Outcomes and Mortality in Type 2 Diabetes With and Without Abdominal Obesity

    Cohort studyT2D & other

  36. Diabetes Obes Metab

    Does Weight Loss Translate to Workplace Gains? Results of an Employment Questionnaire in Adults With Prediabetes and Overweight or Obesity

    Secondary analysisObesity

  37. Diabetes Obes Metab

    GLP ‐1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta‐Analysis of RCTs

    Meta-analysisObesity

  38. Diabetes Obes Metab

    In Vivo Imaging of the Innate Immune System in the Pancreas in New‐Onset and Long‐Standing Type 1 Diabetes

    Mechanistic studyT1D

  39. Diabetes Obes Metab

    Maternal Pregestational and Gestational Diabetes and Neuropsychiatric Risk in Offspring: A Binational Cohort Study

    Cohort studyDiabetes in pregnancy

  40. Diabetes Obes Metab

    Weight Loss Outcomes Between GLP ‐1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta‐Analysis and Meta‐Regression

    Meta-analysisObesity

All 2,200 Briefs in ExploreShowing Briefs 481–520 of 2,200, newest first